# Research Alliance V proposes $62,000,000 share offering

_Published Monday, November 9, 2026 at 5:08 PM EST · Capital · Latest · Tier 2 — Notable_

Research Alliance Corporation V proposes selling 6,200,000 ordinary shares at $10.00 each, according to its SEC prospectus. The acquisition vehicle lists a proposed Nasdaq symbol of RACV and seeks businesses with drug candidates or platforms supported by scientific data and a path toward further clinical development.

Its sponsor has indicated interest in purchasing up to $100.0 million of additional shares when an initial business combination closes. That indication is nonbinding, and neither side is obligated to proceed. Investors in the public offering would receive no warrants.

## Sources

- [SEC EDGAR](https://www.sec.gov/Archives/edgar/data/2137779/000119312526452284/d154414ds1.htm)

---
Canonical: https://techandbusiness.org/newswire/coRbUMBY_HuK938smc6uFT
Published: 2026-11-09T22:08:36.259Z
Story chronology: 2026-11-09T12:00:00.000Z
Retrieved: 2026-11-10T00:16:11.337Z
Publisher: Tech & Business (techandbusiness.org)